Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Double-Blind Extension of Alkermes Study ALK21-003 to Evaluate the Long-Term Safety of Medisorb® Naltrexone

NCT01218971 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT01218971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Double-Blind Extension of Alkermes Study ALK21-003 to Evaluate the Long-Term Safety of Medisorb® Naltrexone
Lead sponsor
Alkermes, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2002
Completion date
September 30, 2004
Enrollment
332 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence